These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 7621099

  • 21. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [Abstract] [Full Text] [Related]

  • 22. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism.
    Castelo-Branco C, Martínez de Osaba MJ, Martínez S, Fortuny A.
    Metabolism; 1996 Jan; 45(1):24-7. PubMed ID: 8544772
    [Abstract] [Full Text] [Related]

  • 23. Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.
    Fruzzetti F, de Lorenzo D, Parrini D, Ricci C.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):831-5. PubMed ID: 8077369
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of long-term inhibition of gonadotrophin secretion by the gonadotrophin-releasing hormone agonist, buserelin, on sex steroid secretion and ovarian morphology in polycystic ovary syndrome.
    Macleod AF, Wheeler MJ, Gordon P, Lowy C, Sönksen PH, Conaglen JV.
    J Endocrinol; 1990 May; 125(2):317-25. PubMed ID: 2115566
    [Abstract] [Full Text] [Related]

  • 26. Treatment with a gonadotropin-releasing hormone agonist in acne or idiopathic hirsutism.
    Faloia E, Filipponi S, Mancini V, Morosini P, De Pirro R.
    J Endocrinol Invest; 1993 Oct; 16(9):675-7. PubMed ID: 8282961
    [Abstract] [Full Text] [Related]

  • 27. Treatment of hirsutism in women with flutamide.
    Marcondes JA, Minnani SL, Luthold WW, Wajchenberg BL, Samojlik E, Kirschner MA.
    Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Factors affecting the degree of hirsutism in patients with polycystic ovary syndrome.
    Guzel AI, Kuyumcuoğlu U, Celik Y.
    Arch Gynecol Obstet; 2012 Mar; 285(3):767-70. PubMed ID: 21909749
    [Abstract] [Full Text] [Related]

  • 30. Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
    Lemay A, Faure N.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1716-22. PubMed ID: 7989480
    [Abstract] [Full Text] [Related]

  • 31. Low-dose ketoconazole treatment in hirsute women.
    Sonino N, Scaroni C, Biason A, Boscaro M, Mantero F.
    J Endocrinol Invest; 1990 Jan; 13(1):35-40. PubMed ID: 2138647
    [Abstract] [Full Text] [Related]

  • 32. The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism.
    Lakryc EM, Motta EL, Soares JM, Haidar MA, de Lima GR, Baracat EC.
    Gynecol Endocrinol; 2003 Feb; 17(1):57-63. PubMed ID: 12724020
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR, Breslau NA, Givens C, Byrd W, Barnett-Hamm C, Marshburn PB.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinical and endocrine effects of flutamide in hyperandrogenic women.
    Fruzzetti F, De Lorenzo D, Ricci C, Fioretti P.
    Fertil Steril; 1993 Nov; 60(5):806-13. PubMed ID: 8224265
    [Abstract] [Full Text] [Related]

  • 38. Hormonal and clinical effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Szilágyi A, Homoki J, Bellyei S, Szabó I.
    Gynecol Endocrinol; 2000 Oct; 14(5):337-41. PubMed ID: 11109973
    [Abstract] [Full Text] [Related]

  • 39. The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment.
    Genazzani AD, Battaglia C, Gamba O, Petraglia F, Malavasi B, Genazzani AR.
    J Assist Reprod Genet; 2000 May; 17(5):269-75. PubMed ID: 10976414
    [Abstract] [Full Text] [Related]

  • 40. A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.
    Bayhan G, Bahçeci M, Demirkol T, Ertem M, Yalinkaya A, Erden AC.
    Clin Exp Obstet Gynecol; 2000 May; 27(3-4):203-6. PubMed ID: 11214952
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.